A Hiroshima University–led clinical trial found that hydrogen supplementation did not significantly improve sleep quality compared with a placebo; however, exploratory analyses suggest that differences in the abundance of ...
Oct 23, 2026
0
80
Type 2 diabetes is becoming increasingly common worldwide. Unlike type 1 diabetes, it is often linked to obesity, a sedentary lifestyle and excess energy intake over many years. Although insulin injections can bring blood ...
Oct 23, 2026
0
46
What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.
Oct 23, 2026
0
32
Without looking back at an appointment calendar or diary or searching Google, what can you recall about the day of Nov. 5, 2021? Unless that date happens to hold an anniversary or other special meaning, probably not too much.
Oct 23, 2026
0
23
Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act ...
Oct 23, 2026
0
339
The activity of six different genes can help determine survival in patients with acute myeloid leukemia (AML), according to a study published in Science Advances. The findings by researchers at the Center for Genomic Regulation ...
Oct 23, 2026
0
10
Medical AI can improve with new patient data, but every update must be checked first. Patients, equipment and ways of working change, and a model trained on older data can gradually get worse without anyone noticing.
Oct 23, 2026
0
10
For years, developers of virtual reality (VR) and augmented reality (AR) technologies have worked to address an unwanted side effect many users experience: cybersickness, a type of motion sickness triggered by moving digital ...
Oct 23, 2026
0
5
Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor that acts as a protective barrier and suppresses the immune ...
Oct 23, 2026
0
84
In a world-first international trial, adding intismeran, a type of personalized therapeutic cancer vaccine made from each patient's own tumor, to pembrolizumab immunotherapy after surgery for high-risk melanoma reduced the ...
Oct 23, 2026
0
27
